Drinane Juliana Papa 4
4 · Organon & Co. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Organon (OGN) Interim Head Juliana Drinane Receives RSU Award
What Happened Juliana Drinane, Interim Head of Manufacturing & Supply at Organon (OGN), received a new award of 125,208 restricted stock units (RSUs) on March 31, 2026. Two earlier RSU grants vested on the same date (6,378 and 10,073 shares); those vested RSUs were converted to shares and a total of 5,636 shares were surrendered to cover tax withholding at $5.70 per share (total withholding ≈ $32,126). The new 125,208 RSU award vests in three equal installments on March 31 of 2027, 2028 and 2029 (each RSU represents one share).
Key Details
- Transaction date: March 31, 2026. Tax withholding price used: $5.70 (Organon closing price on March 30, 2026).
- New award: 125,208 RSUs granted (A); implied market value at $5.70 ≈ $713,686 (award reported at $0 in Form 4 as an equity grant).
- Vested/converted RSUs: 6,378 and 10,073 RSUs converted to shares (M), then 2,185 and 3,451 shares were withheld for taxes (F) for a total withheld of 5,636 shares (~$32,126).
- Shares owned after transaction: not specified in the provided filing.
- Notable footnotes: withholding price per share is plan-required closing price (F1); the 125,208 RSUs vest in three equal annual installments 2027–2029 (F2, F3); the vested conversions relate to prior grants from 2023 and 2025 (F4, F5).
- Filing timeliness: no late filing indicator provided; filing dated April 2, 2026 for transactions on March 31, 2026.
Context
- These transactions are mainly an award (grant of RSUs) plus routine tax withholding when earlier RSUs vested. The conversion entries (M) at $0 reflect RSU vesting/conversion to shares rather than a cash purchase. The withheld shares are a common "sell/withhold-to-cover" mechanism to meet tax obligations and do not necessarily indicate a directional view on the stock.
Insider Transaction Report
Form 4
Drinane Juliana Papa
Interim Head of Mfg & Supply
Transactions
- Exercise/Conversion
Common Stock
2026-03-31+6,378→ 28,798.703 total - Tax Payment
Common Stock
[F1]2026-03-31$5.70/sh−2,185$12,455→ 26,613.703 total - Exercise/Conversion
Common Stock
2026-03-31+10,073→ 36,686.703 total - Tax Payment
Common Stock
[F1]2026-03-31$5.70/sh−3,451$19,671→ 33,235.703 total - Award
Restricted Stock Units
[F2]2026-03-31+125,208→ 125,208 total→ Common Stock (125,208 underlying) - Exercise/Conversion
Restricted Stock Units
[F3][F4]2026-03-31−6,378→ 0 total→ Common Stock (6,378 underlying) - Exercise/Conversion
Restricted Stock Units
[F3][F5]2026-03-31−10,073→ 20,148 total→ Common Stock (10,073 underlying)
Footnotes (5)
- [F1]This price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
- [F2]On March 31, 2026, the Reporting Person was granted 125,208 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
- [F3]Each RSU represents a contingent right to receive one share of Organon common stock.
- [F4]On March 31, 2023, the Reporting Person was granted 19,132 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026.
- [F5]On March 31, 2025, the Reporting Person was granted 30,221 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028.
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Juliana Drinane|2026-04-02